How Artificial Intelligence Is Intensifying the Fight Against COVID-19

It is a major cause for concern that there is no proper vaccination and official treatment available that can help mitigate the coronavirus pandemic so far. Thus, it is imperative for researchers and scientists to explore different approaches and devise ways to counter this global health crisis.

Topics: Software & Enterprise Computing Pharmaceuticals Healthcare Industry Insights

Infographic: Acute Kidney Injury (AKI) Market Insights

Acute Kidney Injury (AKI) is a condition characterized by minor or complete loss of kidney function due to a sudden injury to kidneys. AKI is different from chronic kidney disease, wherein the kidney function is lost over a period of time.

Topics: Healthcare Industry Insights

Steady Growth of U.S. Fertility Clinics Industry Halted by Covid-19

The $6 billion fertility clinics and infertility services industry in the United States had been booming through 2019, thanks to growing demand from American couples that have delayed childbearing, more widespread acceptance of fertility treatment and usage by gay couples, improved success rates, a strong economy, and significant demand from medical tourists from Europe and China.

Topics: Healthcare Industry Insights

COVID-19 and Testing in the US:  Moving Forward

“Had [the US] done more testing from the very beginning and caught cases earlier,” said Dr. Nuzzo of Johns Hopkins, “we would be in a far different place.”

Topics: Diagnostics Healthcare Industry Insights

COVID-19: How It's Different from Previous Pandemics and How It's Impacting World Economies

In light of the ongoing COVID-19 (coronavirus) pandemic, it is imperative to understand the origin of this virus. Previously, such pandemics were often a result of the spread of viruses such as H1N1, H5N1, and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), among others.

Topics: Pharmaceuticals Healthcare Industry Insights

Pace of EUAs Increase as Molecular Diagnostics Vendors Submit COVID-19 Tests

Roche, Hologic, and Thermo Fisher Scientific are among the molecular diagnostic vendors that have received EUAs, or emergency use authorizations, for their tests for the novel coronavirus COVID-19.  

Topics: Diagnostics Healthcare Kalorama Information Industry Insights

The Market Implications of the Coronavirus Outbreaks

Global stocks fell on Monday, with declines in all 11 sectors of the S&P 500, as concerns grew over the rising threat of the coronavirus.

Coronavirus outbreaks have disrupted global supply chains linked to China. According to The Wall Street Journal, some economists estimate that a prolonged Chinese shutdown could cost up to $1 trillion in lost manufacturing output.

Topics: Pharmaceuticals Healthcare Industry Insights

Carrier Screening Market Expected to Witness Impressive Growth

Carrier screening revolves around the gene testing of individuals to understand whether a person is carrying the gene for certain genetic disorders. This test can be performed before or during the time of pregnancy to evaluate the possibility of the baby carrying any type of genetic disease.

Topics: Diagnostics Healthcare Industry Insights

$42 Billion U.S. Addiction Rehab Industry Poised for Growth, and Challenges

Drug and alcohol addiction rehab in the United States is big business — worth $42 billion this year. There are now 15,000+ private treatment facilities and growing.

Topics: Healthcare Industry Insights

4 Key Applications for Artificial Intelligence in Healthcare

In the United States alone, there are roughly 38,000 patents containing the terms artificial intelligence or machine learning (excluding overlap terms). Of all the fields where artificial intelligence (AI) is promising, healthcare seems to be essential. This is because healthcare systems are plagued with problems of staff shortages, ineffective treatments, and increased patient loads and incorrect diagnoses, all of which to a degree could be helped by new technology.  

Topics: Software & Enterprise Computing Healthcare Industry Insights